Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 193

1.

CXCL13 and neopterin concentrations in cerebrospinal fluid of patients with Lyme neuroborreliosis and other diseases that cause neuroinflammation.

Hytönen J, Kortela E, Waris M, Puustinen J, Salo J, Oksi J.

J Neuroinflammation. 2014 Jun 11;11:103. doi: 10.1186/1742-2094-11-103.

2.

Cerebrospinal fluid CXCL13 as a diagnostic marker of neuroborreliosis in children: a retrospective case-control study.

Remy MM, Schöbi N, Kottanattu L, Pfister S, Duppenthaler A, Suter-Riniker F.

J Neuroinflammation. 2017 Aug 31;14(1):173. doi: 10.1186/s12974-017-0948-9.

3.

Cerebrospinal fluid CXCL13 in Lyme neuroborreliosis and asymptomatic HIV infection.

Bremell D, Mattsson N, Edsbagge M, Blennow K, Andreasson U, Wikkelsö C, Zetterberg H, Hagberg L.

BMC Neurol. 2013 Jan 7;13:2. doi: 10.1186/1471-2377-13-2.

4.

Evaluation of two assays for CXCL13 analysis in cerebrospinal fluid for laboratory diagnosis of Lyme neuroborreliosis.

Henningsson AJ, Gyllemark P, Lager M, Skogman BH, Tjernberg I.

APMIS. 2016 Nov;124(11):985-990. doi: 10.1111/apm.12596. Epub 2016 Sep 20.

5.

[CXCL13: a biomarker for acute Lyme neuroborreliosis: investigation of the predictive value in the clinical routine].

Rupprecht TA, Lechner C, Tumani H, Fingerle V.

Nervenarzt. 2014 Apr;85(4):459-64. doi: 10.1007/s00115-014-4020-z. German.

PMID:
24682168
6.

CSF B--lymphocyte chemoattractant (CXCL13) in the early diagnosis of acute Lyme neuroborreliosis.

Ljøstad U, Mygland A.

J Neurol. 2008 May;255(5):732-7. doi: 10.1007/s00415-008-0785-y. Epub 2008 Mar 17. Erratum in: J Neurol. 2008 May;255(5):782. J Neurol. 2008 May;255(5):782.

PMID:
18344056
7.

Cerebrospinal fluid cytokines in Lyme neuroborreliosis.

Pietikäinen A, Maksimow M, Kauko T, Hurme S, Salmi M, Hytönen J.

J Neuroinflammation. 2016 Oct 18;13(1):273.

8.

The chemokine CXCL13 is elevated in the cerebrospinal fluid of patients with neurosyphilis.

Dersch R, Hottenrott T, Senel M, Lehmensiek V, Tumani H, Rauer S, Stich O.

Fluids Barriers CNS. 2015 May 15;12:12. doi: 10.1186/s12987-015-0008-8.

9.

Cerebrospinal Fluid B-lymphocyte Chemoattractant CXCL13 in the Diagnosis of Acute Lyme Neuroborreliosis in Children.

Barstad B, Tveitnes D, Noraas S, Selvik Ask I, Saeed M, Bosse F, Vigemyr G, Huber I, Øymar K.

Pediatr Infect Dis J. 2017 Dec;36(12):e286-e292. doi: 10.1097/INF.0000000000001669.

PMID:
28661964
10.

Prospective study on the chemokine CXCL13 in neuroborreliosis and other aseptic neuroinfections.

Pícha D, Moravcová L, Smíšková D.

J Neurol Sci. 2016 Sep 15;368:214-20. doi: 10.1016/j.jns.2016.05.059. Epub 2016 May 31.

PMID:
27538636
11.

Cerebrospinal fluid chemokine CXCL13 in the diagnosis of neuroborreliosis in children.

Sillanpää H, Skogman BH, Sarvas H, Seppälä IJ, Lahdenne P.

Scand J Infect Dis. 2013 Jul;45(7):526-30. doi: 10.3109/00365548.2013.776700. Epub 2013 Mar 22.

PMID:
23521134
12.

Discriminating Lyme neuroborreliosis from other neuroinflammatory diseases by levels of CXCL13 in cerebrospinal fluid.

van Burgel ND, Bakels F, Kroes AC, van Dam AP.

J Clin Microbiol. 2011 May;49(5):2027-30. doi: 10.1128/JCM.00084-11. Epub 2011 Mar 2.

13.

The chemokine CXCL13 is a key regulator of B cell recruitment to the cerebrospinal fluid in acute Lyme neuroborreliosis.

Rupprecht TA, Plate A, Adam M, Wick M, Kastenbauer S, Schmidt C, Klein M, Pfister HW, Koedel U.

J Neuroinflammation. 2009 Dec 30;6:42. doi: 10.1186/1742-2094-6-42.

14.

The recomBead Borrelia antibody index, CXCL13 and total IgM index for laboratory diagnosis of Lyme neuroborreliosis in children.

Skogman BH, Lager M, Henningsson AJ, Tjernberg I.

Eur J Clin Microbiol Infect Dis. 2017 Nov;36(11):2221-2229. doi: 10.1007/s10096-017-3049-x. Epub 2017 Jul 20.

15.

CXCL13 may improve diagnosis in early neuroborreliosis with atypical laboratory findings.

Borde JP, Meier S, Fingerle V, Klier C, Hübner J, Kern WV.

BMC Infect Dis. 2012 Dec 10;12:344. doi: 10.1186/1471-2334-12-344.

16.

A prospective study on the role of CXCL13 in Lyme neuroborreliosis.

Schmidt C, Plate A, Angele B, Pfister HW, Wick M, Koedel U, Rupprecht TA.

Neurology. 2011 Mar 22;76(12):1051-8. doi: 10.1212/WNL.0b013e318211c39a.

PMID:
21422457
17.

Chemokine CXCL13 concentration in cerebrospinal fluid in patients with neuroborreliosis--own observations.

Kępa L, Oczko-Grzesik B, Sobala-Szczygieł B, Boroń-Kaczmarska A.

Przegl Epidemiol. 2015;69(4):705-10, 851-5. English, Polish.

18.

CXCL13 concentrations in cerebrospinal fluid of patients with Lyme neuroborreliosis and other neurological disorders determined by Luminex and ELISA.

Markowicz M, Schötta AM, Kundi M, Bogovič P, Ogrinc K, Strle F, Stanek G.

Ticks Tick Borne Dis. 2018 Apr 20. pii: S1877-959X(17)30596-4. doi: 10.1016/j.ttbdis.2018.04.008. [Epub ahead of print]

PMID:
29705691
19.

CSF B - lymphocyte chemoattractant (CXCL13) in the early diagnosis of acute Lyme neuroborreliosis.

Ljøstad U, Mygland Å.

J Neurol. 2008 May;255(5):782. doi: 10.1007/s00415-008-0974-8. Epub 2008 Mar 17.

PMID:
27517589
20.

Diagnostic performance of cerebrospinal fluid chemokine CXCL13 and antibodies to the C6-peptide in Lyme neuroborreliosis.

Tjernberg I, Henningsson AJ, Eliasson I, Forsberg P, Ernerudh J.

J Infect. 2011 Feb;62(2):149-58. doi: 10.1016/j.jinf.2010.11.005. Epub 2010 Nov 16.

Supplemental Content

Support Center